A genetic variant strongly linked to Alzheimer’s disease may also worsen neurological damage in people with multiple sclerosis (MS), according to a new study. Researchers found that MS patients carrying the APOE4 variant showed greater signs of neurodegeneration than those without it, including higher levels of nerve damage biomarkers, greater brain tissue damage, and slower…
What literary criticism taught me about living with MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
What literary criticism taught me about living with MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Stem cells transplant do not stop all lesional activity in the brain on
Tweet As NDG Tuesday hasn’t happened yet I have posted this and this looks at stem cells therapy which inhibits relapsing disease but the question is does it stop lesions in the CNS At present it is seen as a treatment of last resort to be used when other things have failed but surely it…
The biggest Michigan game I missed and the lesson MS taught me
Lately, I’ve been thinking about University of Michigan football more than usual. Part of that is because Dan and I recently recorded a podcast with former University of Michigan offensive lineman Brian Wallace. Brian and I share something beyond a connection to Michigan football—we were both diagnosed with Multiple Sclerosis (MS) in 1997. Our conversation…
Jenn sits with the NMSS’s Executive VP of Research, Dr. Bruce Bebo
Bruce Bebo is the Executive Vice President of Research at the National MS Society and leads the team that develops and implements the Society’s comprehensive research strategy. He has been instrumental in advancing the NMSS Pathways to Cures global research strategy and has served on various international scientific committees. Tune in as Dr. Bebo discusses…
High Epstein-Barr antibody levels over time may aid MS diagnosis
Most people with multiple sclerosis (MS) have persistently high levels of antibodies against Epstein-Barr virus (EBV), but these antibodies are much less common in people with other neuroinflammatory diseases and in healthy people, a study found “This study indicates that serial testing for EBV-specific antibodies could serve as an additional biomarker to help distinguish MS…
It’s National MS Awareness Month!
By Samuel Fitch The idea of self-advocacy is something that becomes incredibly important when you live with multiple sclerosis or care for someone who does. There are many ways to advocate for yourself, in medical decisions, in treatment conversations, and … Continue reading → Source: blog.mymsaa.org
Sharing the lessons I’ve learned while living with MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Anti-CD20 in the Middle East
Tweet Rituximab is a WHO MS essessential medicine yet it is not approved for use in MS and not re-imbursed by NHS England. There are three approved anti-CD20 with rituximab most similar to ocrelizumab in terms of dosing and its structure. It is given at doses to kill B cells just like all the other…